Related Experiment Video
Updated: Jun 26, 2025
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
cGAS suppresses β-cell proliferation by a STING-independent but CEBPβ-dependent mechanism
Zixin Cai1, Yan Yang1, Jiaxin Zhong1
1National Clinical Research Center for Metabolic Diseases, Key Laboratory of Cardiometabolic Medicine of Hunan Province, Metabolic Syndrome Research Center, Department of Endocrinology, The Second Xiangya Hospital of Central South University, Changsha, Hunan, China.
Aims/Hypothesis:
cGAS (cyclic GMP-AMP synthase) has been implicated in various cellular processes, but its role in β-cell proliferation and diabetes is not fully understood. This study investigates the impact of cGAS on β-cell proliferation, particularly in the context of diabetes.
Methods:
Utilizing mouse models, including cGAS and STING (stimulator of interferon genes) knockout mice, we explored the role of cGAS in β-cell function. This involved β-cell-specific cGAS knockout (cGASβKO) mice, created by breeding cGAS floxed mice with transgenic mice expressing Cre recombinase under the insulin II promoter. We analyzed cGAS expression in diabetic mouse models, evaluated the effects of cGAS deficiency on glucose tolerance, and investigated the molecular mechanisms underlying these effects through RNA sequencing.
Results:
cGAS expression is upregulated in the islets of diabetic mice and by high glucose treatment in MIN6 cells. Both global cGAS deficiency and β-cell-specific cGAS knockout mice lead to improved glucose tolerance by promoting β-cell mass. Interestingly, STING knockout did not affect pancreatic β-cell mass, suggesting a STING-independent mechanism for cGAS's role in β-cells. Further analyses revealed that cGAS- but not STING-deficiency leads to reduced expression of CEBPβ, a known suppressor of β-cell proliferation, concurrently with increased β-cell proliferation. Moreover, overexpression of CEBPβ reverses the upregulation of Cyclin D1 and D2 induced by cGAS deficiency, thereby regulating β-cell proliferation. These results confirm that cGAS regulation of β-cell proliferation via a CEBPβ-dependent but STING-independent mechanism.
Conclusions/Interpretation:
Our findings highlight the pivotal role of cGAS in promoting β-cell proliferation and maintaining glucose homeostasis, potentially by regulating CEBPβ expression in a STING-independent manner. This study uncovers the significance of cGAS in controlling β-cell mass and identifies a potential therapeutic target for enhancing β-cell proliferation in the treatment of diabetes.
Insights
Cyclic GMP-AMP synthase (cGAS) promotes beta-cell proliferation and glucose homeostasis in diabetes. Its deficiency enhances glucose tolerance by increasing beta-cell mass via a STING-independent pathway involving CEBPβ regulation.
Area of Science:
- Immunology
- Endocrinology
- Molecular Biology
Background:
- Cyclic GMP-AMP synthase (cGAS) is involved in cellular processes, but its specific role in pancreatic beta-cell proliferation and diabetes remains unclear.
- Understanding cGAS's function in beta-cells is crucial for developing novel therapeutic strategies for diabetes.
Purpose of the Study:
- To investigate the impact of cGAS on beta-cell proliferation and function in the context of diabetes.
- To elucidate the molecular mechanisms underlying cGAS-mediated regulation of beta-cell mass and glucose homeostasis.
Main Methods:
- Utilized mouse models, including global and beta-cell-specific cGAS knockout (cGASβKO) mice, and STING knockout mice.
- Analyzed cGAS expression in diabetic models and high glucose-treated MIN6 cells.
- Assessed glucose tolerance, beta-cell mass, and molecular pathways (RNA sequencing, CEBPβ, Cyclin D1/D2 expression).
Main Results:
- cGAS expression is upregulated in diabetic islets and by high glucose.
- cGAS deficiency, both globally and in beta-cells, improves glucose tolerance by increasing beta-cell mass.
- cGAS deficiency reduces CEBPβ expression, leading to increased beta-cell proliferation, a STING-independent mechanism.
Conclusions:
- cGAS plays a critical role in regulating beta-cell proliferation and glucose homeostasis, potentially through CEBPβ modulation in a STING-independent manner.
- The findings identify cGAS as a significant factor in controlling beta-cell mass and suggest it as a potential therapeutic target for diabetes.
Related Concept Videos
01:58Cell Specific Gene Expression
01:09GPCRs Regulate Adenylyl Cylase Activity
01:25cAMP-dependent Protein Kinase Pathways
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
01:16TGF - β Signaling Pathway
01:12GPCR Desensitization